IONS vs MNTSW · rev $514.0M vs rev $2.1M
Ionis Pharmaceuticals Inc (IONS) versus Momentus Inc (MNTSW) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Momentus Inc (MNTSW) common stock listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported MNTSW revenue for 2024-12-31 was $2.1M. Net income was -$34.9M. Revenue was down 31.6% from 2023-12-31 to 2024-12-31. MNTSW currently screens at market cap $0.
IONS currently screens at market cap $12.28B. MNTSW currently screens at market cap $0.
Not investment advice. Open the IONS and MNTSW stock pages for the full models.
Not investment advice.